Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



I'm Buying More Extendicare

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Yes, it was only a couple days ago that my Special Situations portfolio purchased shares of Extendicare (NASDAQOTH: EXETF  ) , but I'm back for more in a big way. As soon as funds hit my account from one outstanding trade, I'm plowing all that money back into Extendicare.

What's to like?
As I detailed in my first write-up, Extendicare is a Canadian health-care company that has announced it's going to divest its American health-care unit through a sale or spinoff. But the market just isn't giving this company the value it deserves. In fact, my figures suggest that you're paying almost nothing at today's price for the American unit. That's odd since the American business should comprise more than half of the company's value.

The stock got hammered earlier this year when it cut its monthly dividend from $0.07 per share to $0.04. But the company explained that move was to align the payout with what its Canadian unit could afford. And the dividend change did that, but investors have largely overlooked the spinoff that should unlock significant value here. This is a typical Greenblatt special situation.

When will this divestiture happen? On the last conference call, management said that it intended to announce a deal by the end of the year.

Foolish bottom line
Extendicare is one of the best deals I've seen in a while and I'm putting my portfolio's money where my mouth is. With cash raised from a sale, I'll be putting about 30% of my equity into Extendicare as soon as I'm able, making it my largest position by far. Like it? Hate it? Join me on my discussion board to hash it out.

Interested in Extendicare or have another stock to share? Check out my discussion board or follow me on Twitter @TMFRoyal.

A top stock for 2014 -- and beyond
There's a huge difference between a good stock, and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it’s one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (0) | Recommend This Article (14)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2761440, ~/Articles/ArticleHandler.aspx, 9/30/2016 1:21:28 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 18,143.45 -195.79 -1.07%
S&P 500 2,151.13 -20.24 -0.93%
NASD 5,269.15 -49.39 -0.93%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 2:16 PM
EXETF $7.12 Up +0.23 +3.32%
Extendicare CAPS Rating: *****